Answers are grounded in this paper and cite their sources.
Overexpression of SIRT1 reduces diabetes-exacerbated MI/R injury and oxidative stress via activating eNOS in diabetic rats. The findings suggest SIRT1 may be a promising novel therapeutic target for diabetic cardiac complications.
No takes yet. Share an insight, caveat, or question.
Ding et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: